BROWN ADVISORY INC – Neurocrine Biosciences, Inc. Transaction History
BROWN ADVISORY INC portfolio value:
$114.16M
portfolio value
BROWN ADVISORY INC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.48% | 5.14K shares | 9.88M | $106.21 | 1.07M |
| Q2 2022 | share | Increase | +5.91% | 57.53K shares | 9.21M | $97.48 | 1.03M |
| Q1 2022 | share | Increase | +3.95% | 36.97K shares | 11.45M | $93.75 | 973.45K |
| Q4 2021 | share | Increase | +18.09% | 143.47K shares | 3.70M | $84.63 | 936.48K |
| Q3 2021 | share | Increase | +1.88% | 14.66K shares | 308K | $95.91 | 793.00K |
| Q2 2021 | share | Increase | +1.82% | 13.88K shares | 1.40M | $97.32 | 778.34K |
| Q1 2021 | share | Increase | +9.56% | 66.72K shares | 7.46M | $97.25 | 764.45K |
| Q4 2020 | share | Increase | +8.49% | 54.58K shares | 5.03M | $95.85 | 697.73K |
| Q3 2020 | share | Increase | +2.83% | 17.70K shares | -14.45M | $96.16 | 643.14K |
| Q2 2020 | share | Increase | +3.47% | 20.96K shares | 23.98M | $122 | 625.43K |
| Q1 2020 | share | Increase | +7.37% | 41.48K shares | -8.19M | $86.55 | 604.47K |
| Q4 2019 | share | Increase | +0.62% | 3.47K shares | 10.09M | $107.49 | 562.98K |
| Q3 2019 | share | Increase | +4.73% | 25.26K shares | 5.31M | $90.11 | 559.51K |
| Q2 2019 | share | Increase | +42.32% | 158.85K shares | 12.03M | $84.43 | 534.24K |
| Q1 2019 | share | Increase | +21.35% | 66.03K shares | 10.98M | $88.1 | 375.38K |
| Q4 2018 | share | Decrease | -1.46% | -4.57K shares | -16.50M | $71.41 | 309.35K |
| Q3 2018 | share | Increase | +3.60% | 10.90K shares | 8.82M | $122.95 | 313.92K |
| Q2 2018 | share | Increase | +7.34% | 20.73K shares | 6.35M | $98.24 | 303.02K |
| Q1 2018 | share | Increase | +1.80% | 4.99K shares | 1.89M | $82.93 | 282.29K |
| Q4 2017 | share | Increase | +1.47% | 4.02K shares | 4.77M | $77.59 | 277.29K |
| Q3 2017 | share | Increase | +10.12% | 25.11K shares | 5.33M | $61.28 | 273.27K |
| Q2 2017 | share | Increase | +2.55% | 6.16K shares | 936K | $46 | 248.15K |
| Q1 2017 | share | Decrease | -36.25% | -137.61K shares | -4.21M | $43.3 | 241.99K |
| Q4 2016 | share | Increase | +9.31% | 32.34K shares | -2.89M | $38.7 | 379.61K |
| Q3 2016 | share | Increase | +8.08% | 25.95K shares | 2.98M | $50.64 | 347.27K |
| Q2 2016 | share | Increase | +3.82% | 11.82K shares | 2.36M | $45.45 | 321.31K |
| Q1 2016 | share | Increase | +35.47% | 81.03K shares | -683K | $39.55 | 309.48K |